Enovix (ENVX) Q2 2026 earnings review

Commercialization Ramps in Niche Markets, While Smartphone Timeline Elongates

Enovix delivered $9.0M in Q2 revenue, up 21% YoY, hitting the top end of guidance. The company is successfully pivoting its near-term commercialization strategy away from its delayed smartphone launch and toward smaller, faster-moving markets: smart eyewear and defense/drones. Eyewear shipments officially began (~2,100 units), and the drone pipeline surged 41% sequentially to $183M. However, despite the top-line beat, non-GAAP gross margin compressed sharply to 19.9% from 26.3% last quarter due to product mix shifts. Meanwhile, the critical smartphone battery qualification timeline remains drawn out, relying on a new hybrid testing protocol through the end of 2026.

🐂 Bull Case

Defense & Drone Pipeline Exploding

The defense and drone opportunity is scaling rapidly, jumping from $130M in Q1 to $183M in Q2. Favorable geopolitical tailwinds (NDAA/TAA compliance) make Enovix's South Korean capacity highly strategic for Western customers.

Smart Eyewear Generating Initial Revenue

The transition from validation to commercial scale is underway. Enovix shipped 2,100 AI-1 batteries for eyewear in Q2 and expects to ship 19,000 against its 50k-pack order in Q3, representing a ~9x sequential acceleration.

🐻 Bear Case

Margins Compressing During Scale-Up

Despite achieving its 7th consecutive quarter of positive gross profit, non-GAAP gross margin fell almost 11 points YoY to 19.9%. If product mix heavily dictates margins, sustained profitability requires higher-margin consumer tech to launch.

Smartphone 'Forever' Tomorrow

Smartphone qualification remains a moving target. The company transitioned away from the 0.7C test to a 'hybrid protocol', but final accelerated cycle-life testing is still not expected to conclude until late 2026, pushing volume revenue out to at least 2027.

⚖️ Verdict: ⚪

Neutral. The commercial traction in smart eyewear and the rapidly expanding drone pipeline are excellent proof points for the technology. However, falling gross margins and the persistent push-out of the massive smartphone TAM temper near-term excitement.

Key Themes

DRIVER NEW 🟢

Drones and Defense: A Critical Near-Term Lifeline

Demand in the drone, defense, and industrial markets is accelerating sharply. The global pipeline for South Korean-manufactured products grew 41% sequentially to $183M. Drone opportunities alone represent over $100M of this pipeline. Crucially, Enovix is benefiting from a macro driver: US government sourcing requirements under the National Defense Authorization Act (NDAA) and Trade Agreements Act (TAA). This geopolitical dynamic gives Enovix's non-China supply chain a massive competitive moat.

DRIVER NEW 🟢

Wearables Moving from Prototype to Product

The smart eyewear segment is officially generating revenue. The company completed key international safety certifications (UN 38.3, UL 2054, KC 62133-2) and shipped ~2,100 AI-1 batteries to a leading reference platform. Growth is accelerating, with a projected 9x sequential increase to ~19,000 packs in Q3. This proves the company's 100% silicon-anode architecture can be manufactured and deployed commercially.

CONCERN 🔴

Margin Contradiction

A troubling data point emerged: despite management's narrative of continuous yield improvements and scale at Fab2, non-GAAP gross margin decelerated drastically, falling from 30.8% a year ago and 26.3% last quarter, down to 19.9% in Q2. Management cited a shift in battery product mix out of South Korea, indicating that the fast-growing defense segment currently commands a lower margin profile than previously expected.

THEME

Manufacturing Bottlenecks Being Addressed

Zone 1 dicing has historically been the primary throughput bottleneck. Yield here improved from ~80% in Q1 to ~84% in Q2. However, to solve this structurally, Enovix is transitioning to a hybrid dicing configuration (laser + mechanical) expected online by year-end. This is a crucial execution milestone required before they can viably mass-produce smartphone batteries.

CONCERN 🔴

The Elusive Smartphone TAM

The narrative around the lead smartphone customer (Honor) continues to elongate. While cells pass 1,000 cycles at 0.2C, the traditional 0.7C legacy test has been entirely scrapped in favor of an iterative 'hybrid protocol' with multiple test conditions. Enovix anticipates finishing this final test in Q4 2026, meaning system-level field testing—and any subsequent revenue—is entirely pushed into 2027.

DRIVER NEW 🟢

Technology Innovation: EX-3M Node & AI-2

Enovix is accelerating its technology roadmap. They produced engineering samples of the next-generation AI-2 battery leveraging the new EX-3M technology node. This innovation reduces separator and current collector thickness, expected to deliver ~20% higher volumetric energy density than the current AI-1. These specific material innovations will be directly ported to future smartphone batteries.

Other KPIs

Free Cash Flow -$31.4 million

Stable. Free cash flow improved modestly from an outflow of -$33.8 million in Q2 2025. With a cash, cash equivalents, and marketable securities balance of $552.1 million, the company has significant runway to fund operations and capacity expansions without an immediate need for capital markets.

GAAP Operating Expenses $44.6 million

Stable. Operating expenses decreased slightly year-over-year from $45.7M. The decrease reflects disciplined cost controls, even as the company scaled its smart eyewear battery shipments and progressed on smartphone cell testing.

Guidance

Q3 2026 Revenue $9.0 - $10.0 million

Accelerating YoY, but decelerating sequentially. The $9.5M midpoint implies a ~19% YoY growth rate (vs $8.0M in Q3 2025), driven by the sharp 9x sequential increase in smart eyewear battery shipments and ongoing defense fulfillment.

Q3 2026 Non-GAAP Operating Loss -$29.0 to -$32.0 million

Stable. The $30.5M midpoint represents a slight sequential increase in operating losses compared to Q2 2026's -$28.8M. This reflects ongoing investments in CapEx and R&D for next-generation technology validation.

Q3 2026 Capital Expenditures $8.0 - $12.0 million

Stable. The $10.0M midpoint is essentially flat compared to the $9.6M spent in Q2 2026, reflecting the methodical build-out of the South Korean manufacturing expansion and Fab2 improvements in Malaysia.

Key Questions

Margin Profile of Drone Segment

Non-GAAP gross margin compressed notably to 19.9% this quarter, driven by the South Korean product mix. As the drone pipeline (now $183M) converts to revenue, should we expect margins to remain compressed compared to the 25-30% range seen historically?

Hybrid Smartphone Testing Protocol

You have replaced the 0.7C test with a 'hybrid protocol' for the lead smartphone OEM. Can you define the exact pass/fail parameters of this new hybrid test, and what happens to the timeline if the cells require further iterative chemistry tweaks?

Mechanical Dicing Capex and Scaling

The transition to hybrid mechanical/laser dicing in Zone 1 is critical for throughput. Are the CapEx requirements for this mechanical equipment higher or lower than the laser systems, and how quickly can it be cloned across the other Fab2 lines?